Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
they will regret selling this low in a week or two I think..good SS
I suffered though the ups and downs of TLss for 1 month but was rewarded quite well..
they will be gone soon enough..but yeah
I wasnt messing with you at all UPS has been in business for 112 years, that is the reason why, this company isnt even a couple of years old..Ask a stranger on the street who is TLSS and UPS see who they know..Now if UPS started in 2017 I would agree 100%..It is my view, didnt mean to ruffle your feathers, thought it was honest..
there are 19233 posts here. its a start
UPS has been here since 1907..that may have something to do with it
smart dinero can be trusted, if you dont believe him call yourself
looks perfect! very nice
maybe but you described a whole day after the first 5 minutes of trading..just thought that was funny
its been 6 minutes..lol
they obviously do not understand business, choose not to read, or click bait bashers with little understanding of the real world..basically people who may not of passed the 8th grade
because its free money..wouldnt you take free money??
lol I didnt read that as bad either..free money
damn, nice post!!
looking pretty good this morning so far! News next week?
could there be a better buy right now in the entire market? You would think people remember 2008
thats a scam firm dont you know?
really??On January 16, 2019, Citron Research published a report entitled "Pipeline Ligand Pipe Dream," detailing sources of Ligand's future revenues by drug candidate, showing how roughly 60% of the Company's milestone payments stem from just two companies. The report alleges that some of Ligand's partners have corporate addresses that are really a home or UPS box, or do not occupy their supposed address. Following this news, the price of Ligand shares fell $21.72, or approximately 16.5%, to close at $110.05 on January 16, 2019.
thats from last year, any update from last Jan?
matter of time here..it is tough waiting to be rich but think this month will be huge for company
nice gapper on LGND
the O/S is 16million, how many shares are they going to dump? Do you know that as fact?
the market will prove you right, soon enough!! thanks for the DD
get it while its hot, get it while its buttered!!
this ticker has about 25 bookmarks this time yesterday, now 76..you brought the gang didnt you!!lol..that pretty big for a day
yesterday it was at 2c. its fast but not that fast, still needs to consolidate at each level..give it a week and you will be shocked I think
getting to be about that time to test HOD again
sweet buy at 74!
no thought in selling yet, volume is just getting started, expecting to play in the .30-.40s next week
meanwhile, big momma LGND having a great day too!
that company is a monster..you will see
thank you for all that you have given, hopefully this ticker gives you a good reason to stay til it hits a buck!!
very nice, Im seeing the exact same thing..hard to find info on this one
so food for thought here too, if LGDNZ would to forward split its stock which is possible, the strike price would be $150..Which psychologically is easier to obtain..just from witnessing apple a few years back
https://www.drudgereport.com/... Pence has the wrong mask on but the order is there!!
This is the proper title of the stock which was acquired yesterday (Roche)...
Ligand Pharmaceuticals Incorporated Roche Contingent Value
My guess as an amateur...basically LGND acquired the company this ticker represents yesterday. And it should bring in some dividend if some certain event happens..Not sure what maybe it(LGND) has to reach a PPS of who knows what.
The acquisition of Icagen brings Ligand the following:
Technology Platform. Icagen’s extensive biological capability focused on ion channels, transporters and x-ray fluorescence, along with a strong track record in novel drug discovery from screening to lead optimization. Ion channels are key components in a wide variety of biological processes that involve rapid changes in cells and have broad therapeutic applicability including cancer, metabolic disease, pain, neurological diseases, infectious diseases and others.
Roche Collaboration to develop and commercialize therapies for neurological diseases. The collaboration provides research funding, potential milestone payments of up to $274 million and tiered royalty payments should a drug be commercialized.
beautiful, thanks
Roche Collaboration to develop and commercialize therapies for neurological diseases. The collaboration provides research funding, potential milestone payments of up to $274 million and tiered royalty payments should a drug be commercialized.